Sinopharm
1099.HK
#2008
Rank
S$10.77 B
Marketcap
$3.45
Share price
-0.74%
Change (1 day)
4.43%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Cash on Hand

Cash on Hand as of December 2023 : S$11.96 Billion

According to Sinopharm's latest financial reports the company has S$11.96 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sinopharm - Cash on Hand chart (from 2008 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$13.07 B41.53%
2021-12-31S$9.23 B-9.31%
2020-12-31S$10.18 B34.67%
2019-12-31S$7.56 B-5.61%
2018-12-31S$8.01 B20.24%
2017-12-31S$6.66 B25.01%
2016-12-31S$5.33 B22.33%
2015-12-31S$4.35 B34.07%
2014-12-31S$3.25 B10.88%
2013-12-31S$2.93 B52.47%
2012-12-31S$1.92 B-28.73%
2011-12-31S$2.69 B85.24%
2010-12-31S$1.45 B-6.38%
2009-12-31S$1.55 B270.93%
2008-12-31S$0.41 B8.7%
2007-12-31S$0.38 B6.81%
2006-12-31S$0.36 B